Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy
Journal of Child Neurology · 2024-10 · 39 (11-12) · 440-445
DOI: 10.1177/08830738241273448 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Child Neurology, online erschienen am 28.08.2024. Verfasst von Dana B Harrar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Cytokines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Here we describe a pediatric patient with febrile infection–related epilepsy syndrome with a good functional and neurologic outcome after treatment with early and aggressive cytokine-directed immunomodulatory therapy and a seizure management strategy that intentionally avoided a barbiturate coma. A 5-year-old previously healthy male presented with staring, behavioral arrest, and encephalopathy evolving to super-refractory status epilepticus. He had had onset of fever 5 days prior. He was treated with early and aggressive immunomodulatory therapy targeted to his evolving cytokine profile. He was also treated with the ketogenic diet, antiseizure medications, and continuous anesthetic infusions. Pentobarbital was purposely avoided. Now, 2½ years later, he attends mainstream school, has attention-deficit hyperactivity disorder (ADHD), mild neurocognitive impairment, and well-controlled epilepsy. By using cytokine-directed immunotherapy and avoiding a barbiturate coma, we were able to successfully treat a pediatric patient with febrile infection-related epilepsy syndrome and achieve a good outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Children's National Hospital, Washington, DC, USA.
- Division of Critical Care Medicine, Children's National Hospital, Washington, DC, USA.
- Division of Rheumatology, Children's National Hospital, Washington, DC, USA.
- Division of Oncology, Children's National Hospital, Washington, DC, USA.
- Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
- Center for Cancer and Immunology Research, Children's National Research Institute, Children's National Hospital, Washington, DC, USA.
ORCID-Profile: Dana B Harrar
Zitieren
APA
Harrar, D. B., Genser, I., Najjar, M., Davies, E., Sule, S., Wistinghausen, B., Goldbach-Mansky, R., & Wells, E. (2024). Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy. Journal of Child Neurology, 39(11-12), 440-445. https://doi.org/10.1177/08830738241273448
Vancouver
Harrar DB, Genser I, Najjar M, Davies E, Sule S, Wistinghausen B, et al. Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy. Journal of Child Neurology. 2024;39(11-12):440-445. doi:10.1177/08830738241273448
BibTeX
@article{Harrar2024,
author = {Harrar, Dana B and Genser, Ilyse and Najjar, Mejdi and Davies, Emily and Sule, Sangeeta and Wistinghausen, Birte and Goldbach-Mansky, Raphaela and Wells, Elizabeth},
title = {Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy},
journal = {Journal of Child Neurology},
year = {2024},
volume = {39},
number = {11-12},
pages = {440--445},
doi = {10.1177/08830738241273448}
}
EUVIMED